UNH vs VRTV: Which Is the Better Buy?

Side-by-side comparison of UnitedHealth Group Incorporated and Veritiv Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
UnitedHealth Group Incorporated Β· Healthcare
$375.21
+28.2% upside to fair value
Med Conviction Grade B High Quality
VS
Veritiv Corporation Β· Industrials
$169.99
-45.0% upside to fair value
Med Conviction Grade D
QuantHub Verdict
UNH has more upside to fair value (+28.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric UNH VRTV
Current Price $375.21 $169.99
Fair Value Estimate $481.06 $93.49
Upside to Fair Value +28.2% -45.0%
Market Cap $340.7B $2.3B
Forward P/E β€” β€”
EV / EBITDA 15.0x 5.4x
Price / Sales 0.8x 0.4x
Price / FCF 14.4x 10.4x
Revenue Growth YoY +0.4% -19.0%
Gross Margin 22.5% 22.7%
Operating Margin 4.8% 5.9%
Return on Equity 14.6% 48.6%
Dividend Yield 2.41% 1.48%
FCF Yield 6.95% 9.57%
Analyst Consensus Strong Buy Hold
Investment Thesis
UNH β€” UnitedHealth Group Incorporated
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
VRTV β€” Veritiv Corporation
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
Metric UNH VRTV
Zone Low $360.80 $70.12
Zone High $408.90 $79.47
In Buy Zone? Yes No
← UNH Research    VRTV Research β†’    All Research